Breaking News

Arno Therapeutics Appoints Interim CEO

July 21, 2014

Zukiwski replaces Glenn Mattes

Alexander Zukiwski, M.D., has been appointed interim chief executive officer of Arno Therapeutics, Inc., effective immediately. Dr. Zukiwski will also continue in his role as vice president and chief medical officer.
Dr. Zukiwski has more than 19 years of experience in pharmaceuticals and biotechnology, including serving as executive vice president, Clinical Research, and chief medical officer at MedImmune, Inc., as well as positions of increasing responsibility with Johnson & Johnson Pharmaceutical Research & Development, LLC (JJPRD) and Ortho Biotech. Dr. Zukiwski replaces Glenn Mattes, who is leaving the company to pursue other interests.
Dr. Arie Belldegrun, chairman of the board, said, "On behalf of the board, we would like to thank Glenn for his contributions to Arno over the last three years. Glenn leaves the company after successfully leading the overall growth of the company, overseeing the progress of our clinical development program while building an outstanding leadership team. We wish Glenn the very best."
Also, Lawrence Kenyon, Arno's chief financial officer, was appointed chief operating officer, expanding his role in the company's business-related functions. Mr. Kenyon has 25 years of financial and operations experience in the pharma and biopharma industries.
Dr. Belldegrun added, "Alex and Larry bring the necessary leadership experience that is vital to Arno's continued success. Together with our very talented and experienced management team, Arno is well positioned to move our clinical development programs forward."

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016